Zobrazeno 1 - 10
of 14
pro vyhledávání: '"E. I. Walter"'
Autor:
E I Walter, Hui Kuo G. Shu, Chi Ming Chang, Lakshmeswari Ravi, Hsing Jien Kung, Lei Ling, Chris M. Castellano, Robert J. Pelley
Publikováno v:
Molecular and Cellular Biology. 14:6868-6878
Avian c-erbB is activated to a leukemia oncogene following truncation of its amino-terminal ligand-binding domain by retroviral insertion. The insertionally activated transcripts encode protein products which have constitutive tyrosine kinase activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52fad661bd797d433d4f8a6ccb809497
https://doi.org/10.1128/mcb.14.10.6868-6878.1994
https://doi.org/10.1128/mcb.14.10.6868-6878.1994
Publikováno v:
Journal of Biological Chemistry. 267:1245-1252
The inositol ring in the glycoinositolphospholipid (GPI) anchor of human decay-accelerating factor (DAF) is unmodified in nucleated cells, whereas it is fatty acid acylated in erythrocytes (Ehu). To assess the effect of this and of the glycerol sn-2-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3c4324bd86beeb135bb7ba3c5361af4
https://doi.org/10.1016/s0021-9258(18)48421-9
https://doi.org/10.1016/s0021-9258(18)48421-9
Publikováno v:
The Journal of Immunology. 145:3836-3841
Decay-accelerating factor (DAF) is a C regulatory protein which functions in membranes to inhibit autologous C activation on cell surfaces. A liposome model was used to study the mechanism of DAF action and examine the effects of membrane-bound glyco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8bc9f1c3238ced48aed3876624f8ea7
https://doi.org/10.4049/jimmunol.145.11.3836
https://doi.org/10.4049/jimmunol.145.11.3836
Publikováno v:
The Journal of Immunology. 144:1030-1036
Human decay-accelerating factor (DAF) proteins expressed on E and nucleated cells differ in their susceptibility to phosphatidylinositol (PI)-specific phospholipase C (PLC) cleavage/release. To investigate the mechanism of this difference, the glycoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fabbf7b56db67bc3584df248cc512df6
https://doi.org/10.4049/jimmunol.144.3.1030
https://doi.org/10.4049/jimmunol.144.3.1030
Publikováno v:
The Journal of biological chemistry. 267(2)
The inositol ring in the glycoinositolphospholipid (GPI) anchor of human decay-accelerating factor (DAF) is unmodified in nucleated cells, whereas it is fatty acid acylated in erythrocytes (Ehu). To assess the effect of this and of the glycerol sn-2-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80679e0b5a495d08856f6918b5d7095f
https://pubmed.ncbi.nlm.nih.gov/1370460
https://pubmed.ncbi.nlm.nih.gov/1370460
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 145(11)
Decay-accelerating factor (DAF) is a C regulatory protein which functions in membranes to inhibit autologous C activation on cell surfaces. A liposome model was used to study the mechanism of DAF action and examine the effects of membrane-bound glyco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7589774511003f5f0da70ca5819db58
https://pubmed.ncbi.nlm.nih.gov/1700997
https://pubmed.ncbi.nlm.nih.gov/1700997
Autor:
J H, Lass, E I, Walter, T E, Burris, H E, Grossniklaus, M I, Roat, D L, Skelnik, L, Needham, M, Singer, M E, Medof
Publikováno v:
Investigative ophthalmologyvisual science. 31(6)
Complement is present in ocular fluids, but the molecular mechanism(s) restricting its activation to exogenous targets and not to autologous ocular cells are currently unknown. To clarify how this control is achieved, monoclonal antibody (mAb)-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::002f1005b4a5ce46127922f155ad7d4d
https://pubmed.ncbi.nlm.nih.gov/1693916
https://pubmed.ncbi.nlm.nih.gov/1693916
Publikováno v:
The Journal of Experimental Medicine
Decay-accelerating factor (DAF) is a 70 kD membrane regulatory protein that prevents the activation of autologous complement on cell surfaces. Using immunohistochemical methods and a radioimmunometric assay based on mAbs to DAF, we found large amount
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6be40f288d59c1c6a232c2ab7c7b384
https://doi.org/10.1084/jem.165.3.848
https://doi.org/10.1084/jem.165.3.848
Publikováno v:
The Journal of Immunology. 141:2924-2928
Recent studies have identified cell-associated proteins that are membrane anchored by glycosyl-inositol-phospholipid structures but the biologic implications of this mode of membrane attachment are incompletely understood. Among proteins anchored in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::151539d0e6caa394f98c974f44203301
https://doi.org/10.4049/jimmunol.141.9.2924
https://doi.org/10.4049/jimmunol.141.9.2924
Autor:
Hui Kuo G. Shu, D J Ayers, E I Walter, Christopher A. Hauer, Robert R. Getty, Richard K. Groger, M E Medof, Mark L. Tykocinski
Publikováno v:
Proceedings of the National Academy of Sciences. 85:3555-3559
Decay-accelerating factor (DAF) is one of a family of cell-associated proteins that undergo posttranslational modifications in which glycolipid anchoring structures are substituted for membrane-spanning sequences. The signals that direct the covalent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad5bad6409436f937282aee17181bbb
https://doi.org/10.1073/pnas.85.10.3555
https://doi.org/10.1073/pnas.85.10.3555